Definiens

Definiens (Booth 6075) is introducing a new image analysis application that allows radiologists to analyze lymph nodes volumetrically and compare them over time. The technology addresses formerly unmet needs by enabling radiologists to rapidly and accurately identify, analyze and track lymph nodes of interest, facilitating earlier detection of the metastatic spread of cancer, the company says. Definiens aims to provide image analysis solutions for cell- and tissue-based assays and medical imaging, such as x-rays, CT and MRI studies.

Around the web

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.